Dasatinib Drugs Are Used For Treating Chronic Myelogenous Leukemia (CML) And Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Dasatinib drugs are an inhibitor of multiple tyrosine kinases. It is active against Philadelphia-chromosome positive (Ph+) acute lymphocytic leukemia (ALL), in patients who have received …